Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node.

(2017) A. E. Giuliano et al.   JOURNAL OF CLINICAL ONCOLOGY

Evolution of Axillary Nodal Staging in Breast Cancer: Clinical Implications of the ACOSOG Z0011 Trial

(2017) Miraj Shah-Khan et al.   Cancer Control

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

(2016) Armando E. Giuliano et al.   ANNALS OF SURGERY

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment

(2016) Oleg Gluz et al.   JOURNAL OF CLINICAL ONCOLOGY

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

(2016) Fatima Cardoso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regional Nodal Irradiation in Early-Stage Breast Cancer

(2015) Timothy J. Whelan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis

(2013) Tracey DiSipio et al.   LANCET ONCOLOGY

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

(2013) Viviana Galimberti et al.   LANCET ONCOLOGY

Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000

(2012) Montserrat Solá et al.   ANNALS OF SURGICAL ONCOLOGY

The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?

(2012) U. Güth et al.   EJSO

To Cut Is to Cure: Can We Really Apply Z11 in Practice?

(2011) Monica Morrow et al.   ANNALS OF SURGICAL ONCOLOGY

Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy

(2011) Bassam S. Abdulkarim et al.   JOURNAL OF CLINICAL ONCOLOGY

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

(2010) Volker Moebus et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer

(2009) Karl Y. Bilimoria et al.   JOURNAL OF CLINICAL ONCOLOGY